There is more than one way for triple-negative breast cancer to become resistant to therapy
Medical Xpress
February 26, 2026
About 50% of triple-negative breast cancer (TNBC) patients develop resistance to therapy. When resistance arises, tumors are more likely to come back after the original treatment, significantly reducing the chances of survival. Researchers at Baylor College of Medicine have discovered that there is more than one way TNBC can become immune to therapy.
Verticals
healthmedical
Originally published on Medical Xpress on 2/26/2026